These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 24831696)

  • 21. NALP3 is not necessary for early protection against experimental tuberculosis.
    Walter K; Hölscher C; Tschopp J; Ehlers S
    Immunobiology; 2010; 215(9-10):804-11. PubMed ID: 20579764
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mycobacterium tuberculosis PstS1 amplifies IFN-γ and induces IL-17/IL-22 responses by unrelated memory CD4+ T cells via dendritic cell activation.
    Palma C; Schiavoni G; Abalsamo L; Mattei F; Piccaro G; Sanchez M; Fernandez C; Singh M; Gabriele L
    Eur J Immunol; 2013 Sep; 43(9):2386-97. PubMed ID: 23719937
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mycobacterium tuberculosis Rv3628 drives Th1-type T cell immunity via TLR2-mediated activation of dendritic cells and displays vaccine potential against the hyper-virulent Beijing K strain.
    Kim WS; Kim JS; Cha SB; Kim H; Kwon KW; Kim SJ; Han SJ; Choi SY; Cho SN; Park JH; Shin SJ
    Oncotarget; 2016 May; 7(18):24962-82. PubMed ID: 27097115
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antigens of
    Choreño-Parra JA; Jiménez-Álvarez LA; Muñoz-Torrico M; Ramírez-Martínez G; Jiménez-Zamudio LA; Salinas-Lara C; García-Latorre EA; Zúñiga J
    Front Immunol; 2020; 11():582414. PubMed ID: 33117393
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IL-17 Production of Neutrophils Enhances Antibacteria Ability but Promotes Arthritis Development During Mycobacterium tuberculosis Infection.
    Hu S; He W; Du X; Yang J; Wen Q; Zhong XP; Ma L
    EBioMedicine; 2017 Sep; 23():88-99. PubMed ID: 28821374
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential Targeting of c-Maf, Bach-1, and Elmo-1 by microRNA-143 and microRNA-365 Promotes the Intracellular Growth of
    Tamgue O; Gcanga L; Ozturk M; Whitehead L; Pillay S; Jacobs R; Roy S; Schmeier S; Davids M; Medvedeva YA; Dheda K; Suzuki H; Brombacher F; Guler R
    Front Immunol; 2019; 10():421. PubMed ID: 30941122
    [No Abstract]   [Full Text] [Related]  

  • 27. Efficacy and immunogenicity of different BCG doses in BALB/c and CB6F1 mice when challenged with H37Rv or Beijing HN878.
    Khatri B; Keeble J; Dagg B; Kaveh DA; Hogarth PJ; Ho MM
    Sci Rep; 2021 Dec; 11(1):23308. PubMed ID: 34857776
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-alpha /beta.
    Manca C; Tsenova L; Bergtold A; Freeman S; Tovey M; Musser JM; Barry CE; Freedman VH; Kaplan G
    Proc Natl Acad Sci U S A; 2001 May; 98(10):5752-7. PubMed ID: 11320211
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The hypervirulent Mycobacterium tuberculosis strain HN878 induces a potent TH1 response followed by rapid down-regulation.
    Ordway D; Henao-Tamayo M; Harton M; Palanisamy G; Troudt J; Shanley C; Basaraba RJ; Orme IM
    J Immunol; 2007 Jul; 179(1):522-31. PubMed ID: 17579073
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential requirement of formyl peptide receptor 1 in macrophages and neutrophils in the host defense against Mycobacterium tuberculosis Infection.
    Nafiz TN; Sankar P; Mishra LK; Rousseau RP; Saqib M; Subbian S; Parihar SP; Mishra BB
    Sci Rep; 2024 Oct; 14(1):23595. PubMed ID: 39384825
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A role for IL-18 in protective immunity against Mycobacterium tuberculosis.
    Schneider BE; Korbel D; Hagens K; Koch M; Raupach B; Enders J; Kaufmann SH; Mittrücker HW; Schaible UE
    Eur J Immunol; 2010 Feb; 40(2):396-405. PubMed ID: 19950174
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HIV-1 Tat protein vaccination in mice infected with Mycobacterium tuberculosis is safe, immunogenic and reduces bacterial lung pathology.
    Cafaro A; Piccaro G; Altavilla G; Gigantino V; Matarese G; Olivieri E; Ferrantelli F; Ensoli B; Palma C
    BMC Infect Dis; 2016 Aug; 16(1):442. PubMed ID: 27549342
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protection and Long-Lived Immunity Induced by the ID93/GLA-SE Vaccine Candidate against a Clinical Mycobacterium tuberculosis Isolate.
    Baldwin SL; Reese VA; Huang PW; Beebe EA; Podell BK; Reed SG; Coler RN
    Clin Vaccine Immunol; 2016 Feb; 23(2):137-47. PubMed ID: 26656121
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IL-1 receptor-mediated signal is an essential component of MyD88-dependent innate response to Mycobacterium tuberculosis infection.
    Fremond CM; Togbe D; Doz E; Rose S; Vasseur V; Maillet I; Jacobs M; Ryffel B; Quesniaux VF
    J Immunol; 2007 Jul; 179(2):1178-89. PubMed ID: 17617611
    [TBL] [Abstract][Full Text] [Related]  

  • 35. BCG vaccination confers poor protection against M. tuberculosis HN878-induced central nervous system disease.
    Tsenova L; Harbacheuski R; Sung N; Ellison E; Fallows D; Kaplan G
    Vaccine; 2007 Jul; 25(28):5126-32. PubMed ID: 17241704
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glibenclamide alters interleukin-8 and interleukin-1β of primary human monocytes from diabetes patients against Mycobacterium tuberculosis infection.
    Kewcharoenwong C; Saenwongsa W; Willcocks SJ; Bancroft GJ; Fletcher HA; Lertmemongkolchai G
    Tuberculosis (Edinb); 2020 Jul; 123():101939. PubMed ID: 32452426
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lipid mediators in innate immunity against tuberculosis: opposing roles of PGE2 and LXA4 in the induction of macrophage death.
    Chen M; Divangahi M; Gan H; Shin DS; Hong S; Lee DM; Serhan CN; Behar SM; Remold HG
    J Exp Med; 2008 Nov; 205(12):2791-801. PubMed ID: 18955568
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Toll-like receptor 4 signaling-mediated responses are critically engaged in optimal host protection against highly virulent
    Park J; Kim H; Kwon KW; Choi HH; Kang SM; Hong JJ; Shin SJ
    Virulence; 2020 Dec; 11(1):430-445. PubMed ID: 32403973
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Recent advances in tuberculosis immunity].
    Akagawa KS
    Kekkaku; 2012 Feb; 87(2):61-70. PubMed ID: 22514942
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypervirulent M. tuberculosis W/Beijing strains upregulate type I IFNs and increase expression of negative regulators of the Jak-Stat pathway.
    Manca C; Tsenova L; Freeman S; Barczak AK; Tovey M; Murray PJ; Barry C; Kaplan G
    J Interferon Cytokine Res; 2005 Nov; 25(11):694-701. PubMed ID: 16318583
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.